Skip to content

Impact of Two Different Types of Sedation on ICEB

Evaluation of the Effects of Two Different Sedation Protocols Used in Patients Undergoing Spinal Anesthesia on Cardiac Electrophysiology

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05757063
Enrollment
70
Registered
2023-03-07
Start date
2023-03-01
Completion date
2023-08-01
Last updated
2023-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dexmedetomidine, Electrophysiological Balance Index, Knee Osteoarthritis, Propofol, QT Dispersion, QT Interval, Variation in, Tp-e Interval

Brief summary

The QT interval is a measure of the combination of cardiac depolarization and repolarization as it encompasses both the QRS complex and the J-T interval. QT, QTc, QTd prolongation or shortening has been associated with ventricular arrhythmias . In order to define non-torsogenic drug-induced arrhythmias, the index of cardio-electrophysiological balance (iCEB), which is a new marker calculated with the QT/QRS formula, has been defined. In our study, we planned to evaluate the effects of dexmedetomidine and propofol on cardiac electrophysiology with all these parameters, especially the newly defined iCEB.

Detailed description

Seventy patients who underwent operation under regional anesthesia and received intraoperative sedation will be included in the study. The patients will be divided into two groups, Group D (dexmedetomidine) and Group P (propofol). Sedative agent infusion will be started immediately after spinal anesthesia is administered. Preoperative ASA (American Society of Anesthesiologists) scores, demographic data, comorbidities and medications used will be recorded. Vitals and ECG prior to spinal anesthesia will be recorded. After that, spinal anesthesia will be applied and vitals and ECG will be recorded at 1, 5, 10, 15, 45 and 75 minutes. The sedation levels of the patients will be measured noninvasively by bispectral index (BIS) monitoring. Patients will be kept within the limits of light sedation. The maximum dose of 1.4 micrograms/kg/hour in the dexmedetomidine group (group D, n=35) and 4.5 milligrams/kg/hour in the propofol group (group P, n=35) will not be exceeded. The following parameters were set as the safety endpoint during sedation: * Respiratory rate ≤8 * SpO2; 95 * Heart rate; 40 * Systolic blood pressure;80 At these endpoints, the patient's sedation dose will be reduced regardless of the BIS value. During sedation, patients will be given 3 liters of nasal oxygen per minute, which can be increased according to need. Just before and 1st, 5th, 10th, 15th, 45th, 75th minutes after spinal anesthesia systolic arterial pressure, diastolic arterial pressure, mean arterial pressure,peak heart rate, oxygen saturation, bispectral index, QT time, QTc, QT distribution, Tpe, iCEB will be evaluated.

Interventions

After spinal anesthesia, patients will be sedated with propofol.

After spinal anesthesia, patients will be sedated with dexmedetomidine.

Sponsors

Ankara City Hospital Bilkent
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients with ASA Ⅰ-Ⅱ , * 18-80 years old, who will be operated under spinal anesthesia

Exclusion criteria

* Hypersensitivity to the propofol,dexmedotimidine * preoperative QTc prolongation * preoperative heart disease * use of drugs that affect the QT interval * severe sinus bradycardia * preoperative electrolyte abnormalities * liver and kidney function abnormalities * non-sinus rhythm

Design outcomes

Primary

MeasureTime frameDescription
ICEBcİntraoperative 10th minuteQTc/QRS formula

Secondary

MeasureTime frameDescription
ICEBcBaseline,İntraoperative 1th,5th,15th,30th,45th,75th minuteQTc/QRS formula
QTBaseline,İntraoperative 1th,5th,10th,15th,30th,45th,75th minuteThe investigator will assess the QT interval
QTcBaseline,İntraoperative 1th,5th,10th,15th,30th,45th,75th minuteThe investigator will assess the QTc interval
QTdBaseline,İntraoperative 1th,5th,10th,15th,30th,45th,75th minutemaxQT-minQT
ICEBBaseline,İntraoperative 1th,5th,10th,15th,30th,45th,75th minuteIndex of cardio-electrophysiological balance (iCEB); calculated as QT distance divided by QRS duration (QT/ QRS), it will be calculated from the ECG.
Heart RateBaseline,İntraoperative 1th,5th,10th,15th,30th,45th,75th minuteThe investigator will assess the Heart Rate from ECG
Bispektral indexBaseline,İntraoperative 1th,5th,10th,15th,30th,45th,75th minutebispectral index measurement
non invaziv systolic blood pressureBaseline,İntraoperative 1th,5th,10th,15th,30th,45th,75th minutenon invasive systolic blood pressure measurement
non invaziv diastolic blood pressureBaseline,İntraoperative 1th,5th,10th,15th,30th,45th,75th minutenon invasive diastolic blood pressure measurement
TpeBaseline,İntraoperative 1th,5th,10th,15th,30th,45th,75th minuteTpeak-Tend

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026